Medexus Pharmaceuticals Inc. reported earnings results for the first quarter ended June 30, 2023. For the first quarter, the company reported net income was USD 0.651 million compared to net loss of USD 1.4 million a year ago. Basic earnings per share from continuing operations was USD 0.03 compared to basic loss per share from continuing operations of USD 0.07 a year ago.

Diluted earnings per share from continuing operations was USD 0.03 compared to diluted loss per share from continuing operations of USD 0.07 a year ago.